EVAXEvaxion Biotech A/S

$20M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$8M

Net Income

-$8M

EPS (Diluted)

$-15.44

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$40M

Total Liabilities

$8M

Stockholders' Equity

$32M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$8M	-$5M	-66.2%
Net Income	-$8M	-$4M	-96.3%

EVAX Q4 2021 Earnings — Evaxion Biotech A/S Revenue & Financial Results | Market Cap Arena